A long-term extension study of AG-1749 in patients on concomitant long-term non-steroidal antiinflammatory drug (NSAIDs) use
Phase 3
- Conditions
- Prevention of ulcer associated with NSAIDs
- Registration Number
- JPRN-jRCT2080220831
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.Patients who have finished the preceding confirmatory anti-ulcer efficacy study
2.Patients who are on oral NSAIDs therapy at the time of consent and who require continued long-term NSAIDs use even after the start of study treatment in this study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method